ID3 and TCF4

  • Number of citations of the paper that reports this interaction (PMID 11591653)
  • 37
  • Data Source:
  • HPRD (in vitro, two hybrid, in vivo)

ID3

TCF4

Gene Name inhibitor of DNA binding 3, dominant negative helix-loop-helix protein transcription factor 4
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 36 interactors: ADD1 ATF3 CBFA2T2 CDK2 CNOT3 CSK E2F4 ELK1 ELK4 FAM74A1 FHL2 GATA4 GNB2 GTF2A1L HES1 ID4 IFI16 IKBKG MLX MYF5 MYF6 MYOD1 MYOG PAX5 PRDM14 PUF60 RND1 RUNX1T1 SAP30 SREBF1 TCF12 TCF3 TCF4 ZNF3 ZNF408 ZNF626 173 interactors: AES AQP1 AR ARHGEF1 ARMC7 ASCL1 ASCL3 ASCL4 ASPSCR1 ATP6V1B2 BCAS2 BCL2L2 BZRAP1 C19orf66 C1orf109 C9orf171 CABP5 CALM1 CALM2 CALM3 CCDC101 CDC73 CDKN1A CDKN2C CHAF1A CHCHD2 CHIC2 CKS1B CTBP1 CTNNB1 DDX6 DEF6 DGCR6 DMRT3 EFHC1 EIF4E2 EIF4EBP1 EP300 EPB41L3 EPHB6 EXOSC1 FAH FAM124B FAM74A4 FERD3L FLAD1 FLNA FRS3 GEM GLRX3 GNG10 GOLGA8EP GOLGA8F GORASP2 GTF3C5 GUCD1 HAND2 HAT1 HBP1 HIC1 HSPB7 ID1 ID2 ID3 ID4 INS JUN JUP KCTD14 KLC3 KLHL32 LASP1 LENG1 LGALS14 LMO1 LMO4 LNPEP LYL1 MAD2L2 MAGOHB MAPKBP1 MATN3 MEMO1 MEN1 MLLT6 MORN4 MRFAP1L1 MRPL10 MSC MSRB3 MVP MYO5B MYOD1 NCK2 NDOR1 NEK6 NEK8 NEU4 NEUROD1 NEUROG1 NME7 NMUR2 NOL9 NR2C2AP NR4A1 NUDT10 ORC4 OSGIN1 OTUD4 PARK2 PARP1 PATE1 PBLD PIN1 PLEKHN1 POLR1A POLR1C PPIA PPIL1 PPP1R18 PRKAA2 PRKAB2 PSEN1 PSMA1 PSMG2 PTF1A PTGER3 RAB41 RABIF RECK RELA REXO1L6P RNF138 RSPH14 RUNX1T1 SCOC SEC14L4 SIGLEC6 SLC39A13 SLC4A1AP SMCP SMOC1 SPATC1L SPG21 SRSF2 STAMBPL1 STK16 STX11 SUMO1 SZT2 TAL1 TAL2 TAPBPL TCEA2 TCF3 TCL1A TLE1 TMEM213 TRAPPC2L TSSC4 TSSK3 TWIST2 TXNL4B USP4 UTP23 VPS28 XRCC5 XRCC6 ZDHHC24 ZNF124 ZNF205-AS1 ZNF417 ZNF587
Entrez ID 3399 6925
HPRD ID 02608 03780
Ensembl ID ENSG00000117318 ENSG00000196628
Uniprot IDs Q02535 B3KVA4 E9PH57 H3BTP3 P15884
PDB IDs 2LFH 2KWF
Enriched GO Terms of Interacting Partners?
Tagcloud ?
accumulating  associates  box  compartment  competition  constitute  developmentally  e2a  e47  enforced  erythroid  gal  helix  heterodimers  hypermethylation  implicates  k562  lineages  lymphoid  metazoa  overlapping  shift  specificities  strict  suggestive  tal1  vicinity  vp16 
action  activities  agent  beta  biejiajian  catenin  cultured  cyclin  cytoplasmic  d1  downstream  expressions  fed  hepatocellular  hepg2  immunofluorescence  inhibiting  invasiveness  lowered  luciferase  mmp  pills  qrt  sera  serve  suppress  underlying  whose  wnt 
Tagcloud (Difference) ?
accumulating  associates  box  compartment  competition  constitute  developmentally  e2a  e47  enforced  erythroid  gal  helix  heterodimers  hypermethylation  implicates  k562  lineages  lymphoid  metazoa  overlapping  shift  specificities  strict  suggestive  tal1  vicinity  vp16 
action  activities  agent  beta  biejiajian  catenin  cultured  cyclin  cytoplasmic  d1  downstream  expressions  fed  hepatocellular  hepg2  immunofluorescence  inhibiting  invasiveness  lowered  luciferase  mmp  pills  qrt  sera  serve  suppress  underlying  whose  wnt 
Tagcloud (Intersection) ?